Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Forty-seven patients with head and neck cancer were treated with thrice-a-day fractionation (200 rad Co/sup 60/ three times per day, 5 days per week) to a total tumor dose of 4800 to 5400 rad over 9 to 11 days. Of this group, 22 advanced oral and pharyngo-laryngeal cancer patients had a 24-month follow-up. While early tolerance and skin reaction were quite acceptable, the rate of serious mucosal radionecrosis was high (55%) and 2-year survival was poor (14%). Less advantage was found over conventional fractionation; the probable causes, i.e., single dose size and irradiation volume dimension, are discussed.
Research Organization:
Unversita di Parma e Servizio di Radioterapia, Parma, Italy
OSTI ID:
6643384
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 7:1; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck
Journal Article · Wed Nov 30 23:00:00 EST 1977 · Am. J. Roentgenol.; (United States) · OSTI ID:5340116

Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck
Journal Article · Wed Nov 30 23:00:00 EST 1977 · Am. J. Roentgenol.; (United States) · OSTI ID:6630101

Short course high fractional dose irradiation in advanced and recurrent head and neck cancer
Conference · Mon Oct 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5511763